gene-delivered antibody therapies (Oxford BioMedica)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namegene-delivered antibody therapies (Oxford BioMedica)
Drug Alias Nameanti-OBA1 ScFv fusions gene therapy (Oxford BioMedica)FusitAbs
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOxford Biomedica PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxford Biomedica PLC
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A